Abstract
Terbinafine is a commonly used antifungal agent, but safety data of its use in pregnancy are limited. To examine the association between oral and topical terbinafine exposure in pregnancy and the risk of major malformations and spontaneous abortion. A nationwide, registry-based cohort study was conducted in Denmark from January 1, 1997, to December 31, 2016, in a cohort of 1 650 649 pregnancies. Data analysis was performed from July 11 to October 20, 2019. Pregnancies were matched on propensity scores comparing oral terbinafine exposed vs unexposed (1:10 ratio), topical terbinafine exposed vs unexposed (1:10), and oral vs topical terbinafine exposed (1:1). Filled prescriptions for oral or topical terbinafine. Logistic regression was used to compute prevalence odds ratios for the primary outcome of major malformations and Cox proportional hazards regression was used to compute hazard ratios for the secondary outcome of spontaneous abortion. Based on a cohort of 1 650 649 pregnancies, oral terbinafine-exposed (n = 891 pregnancies; mean [SD] age, 30.4 [6] years) and topical terbinafine-exposed (n = 3174; mean [SD] age, 29.5 [5.4] years) pregnancies were identified; up to a total of 40 650 unexposed pregnancies were included for th...Continue Reading
References
Oct 1, 1990·Journal of the American Academy of Dermatology·J E Birnbaum
Mar 30, 1999·Annales de dermatologie et de vénéréologie·M L Bouyssou-Gauthier, J M Bonnetblanc
Aug 10, 1999·Drugs·K J McClellanA Markham
Jul 29, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J D Sobel
Jul 28, 2001·Clinical Pharmacokinetics·D Debruyne, A Coquerel
Jul 3, 2002·Pediatrics·UNKNOWN Committee on Drugs. American Academy of Pediatrics
Mar 8, 2003·Scandinavian Journal of Public Health·Helle LarsenHenrik T Sørensen
Jan 25, 2005·American Journal of Clinical Dermatology·Amber A Kyle, Mark V Dahl
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carol A KauffmanUNKNOWN Infectious Diseases Society of America
Aug 4, 2011·Scandinavian Journal of Public Health·Carsten Bøcker Pedersen
Aug 4, 2011·Scandinavian Journal of Public Health·Elsebeth LyngeMatejka Rebolj
Aug 4, 2011·Scandinavian Journal of Public Health·Helle Wallach KildemoesJesper Hallas
Oct 20, 2012·Archives of Disease in Childhood. Fetal and Neonatal Edition·S D SieM M van Weissenbruch
Jul 26, 2013·Scandinavian Journal of Public Health·Anja Nygaard JohansenParisa Gazerani
Sep 12, 2013·Circulation. Cardiovascular Quality and Outcomes·M Alan BrookhartTil Stürmer
Oct 15, 2013·Statistics in Medicine·Peter C Austin
Nov 29, 2013·Reproductive Toxicology·Orna Diav-CitrinAsher Ornoy
Feb 18, 2014·Journal of the American Academy of Dermatology·Jenny E MuraseDaniel C Butler
Sep 11, 2014·The Journal of Antimicrobial Chemotherapy·Benoît PilmisCaroline Charlier
Dec 18, 2014·Clinical Obstetrics and Gynecology·Kelly H Tyler
Jul 1, 2018·Journal of the American Academy of Dermatology·Shari R Lipner, Richard K Scher
Citations
Sep 30, 2020·Expert Opinion on Drug Safety·Jose W Ricardo, Shari R Lipner
Jan 16, 2021·Journal of the American Academy of Dermatology·Niklas Worm AnderssonJon Trærup Andersen
Oct 24, 2020·Drug and Therapeutics Bulletin
Aug 1, 2020·Annales de dermatologie et de vénéréologie·J-L Schmutz
Jul 6, 2021·Indian Journal of Dermatology, Venereology and Leprology·Shyam B VermaResham Vasani